143 related articles for article (PubMed ID: 35536548)
61. Inhibition of IL-17 as a pharmacological approach for IBD.
Fitzpatrick LR
Int Rev Immunol; 2013; 32(5-6):544-55. PubMed ID: 23886112
[TBL] [Abstract][Full Text] [Related]
62. Retroviral cyclin controls cyclin-dependent kinase 8-mediated transcription elongation and reinitiation.
Birkenheuer CH; Brewster CD; Quackenbush SL; Rovnak J
J Virol; 2015 May; 89(10):5450-61. PubMed ID: 25741012
[TBL] [Abstract][Full Text] [Related]
63. A kinase-independent role for CDK8 in BCR-ABL1
Menzl I; Zhang T; Berger-Becvar A; Grausenburger R; Heller G; Prchal-Murphy M; Edlinger L; Knab VM; Uras IZ; Grundschober E; Bauer K; Roth M; Skucha A; Liu Y; Hatcher JM; Liang Y; Kwiatkowski NP; Fux D; Hoelbl-Kovacic A; Kubicek S; Melo JV; Valent P; Weichhart T; Grebien F; Zuber J; Gray NS; Sexl V
Nat Commun; 2019 Oct; 10(1):4741. PubMed ID: 31628323
[TBL] [Abstract][Full Text] [Related]
64. What's the next best cytokine target in IBD?
MacDonald TT; Biancheri P; Sarra M; Monteleone G
Inflamm Bowel Dis; 2012 Nov; 18(11):2180-9. PubMed ID: 22508526
[TBL] [Abstract][Full Text] [Related]
65. Potent anti-inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells.
To WS; Aungier SR; Cartwright AJ; Ito K; Midwood KS
Br J Pharmacol; 2015 Aug; 172(15):3805-16. PubMed ID: 25891413
[TBL] [Abstract][Full Text] [Related]
66. In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183.
Schrecengost RS; Green CL; Zhuang Y; Keller SN; Smith RA; Maines LW; Smith CD
J Pharmacol Exp Ther; 2018 Apr; 365(1):107-116. PubMed ID: 29434052
[TBL] [Abstract][Full Text] [Related]
67. IL-16 induces intestinal inflammation via PepT1 upregulation in a pufferfish model: new insights into the molecular mechanism of inflammatory bowel disease.
Wang P; Lu YQ; Wen Y; Yu DY; Ge L; Dong WR; Xiang LX; Shao JZ
J Immunol; 2013 Aug; 191(3):1413-27. PubMed ID: 23817423
[TBL] [Abstract][Full Text] [Related]
68. Mediator cyclin-dependent kinases upregulate transcription of inflammatory genes in cooperation with NF-κB and C/EBPβ on stimulation of Toll-like receptor 9.
Yamamoto S; Hagihara T; Horiuchi Y; Okui A; Wani S; Yoshida T; Inoue T; Tanaka A; Ito T; Hirose Y; Ohkuma Y
Genes Cells; 2017 Mar; 22(3):265-276. PubMed ID: 28151579
[TBL] [Abstract][Full Text] [Related]
69. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
[TBL] [Abstract][Full Text] [Related]
70. Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease.
Chaudhary CL; Gurung P; Jang S; Banskota S; Nam TG; Kim JA; Jeong BS
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1-20. PubMed ID: 31619080
[TBL] [Abstract][Full Text] [Related]
71. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A; Lelong M; Jeljeli M; Piquet-Pellorce C; Morzadec C; Ballerie A; Jouneau S; Jego P; Vernhet L; Batteux F; Fardel O; Lecureur V
Biochem Pharmacol; 2020 Aug; 178():114103. PubMed ID: 32562787
[TBL] [Abstract][Full Text] [Related]
72. Melatonin-loaded chitosan nanoparticles endows nitric oxide synthase 2 mediated anti-inflammatory activity in inflammatory bowel disease model.
Soni JM; Sardoiwala MN; Choudhury SR; Sharma SS; Karmakar S
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112038. PubMed ID: 33947538
[TBL] [Abstract][Full Text] [Related]
73. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.
Epstein J; Docena G; MacDonald TT; Sanderson IR
Br J Nutr; 2010 Mar; 103(6):824-32. PubMed ID: 19878610
[TBL] [Abstract][Full Text] [Related]
74. CDK8 Kinase Activity Promotes Glycolysis.
Galbraith MD; Andrysik Z; Pandey A; Hoh M; Bonner EA; Hill AA; Sullivan KD; Espinosa JM
Cell Rep; 2017 Nov; 21(6):1495-1506. PubMed ID: 29117556
[TBL] [Abstract][Full Text] [Related]
75. Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?
Philip S; Kumarasiri M; Teo T; Yu M; Wang S
J Med Chem; 2018 Jun; 61(12):5073-5092. PubMed ID: 29266937
[TBL] [Abstract][Full Text] [Related]
76. Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease.
Verstockt B; Van Assche G; Vermeire S; Ferrante M
Expert Opin Biol Ther; 2017 Jan; 17(1):31-47. PubMed ID: 27817215
[TBL] [Abstract][Full Text] [Related]
77. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder.
Schneider EV; Böttcher J; Blaesse M; Neumann L; Huber R; Maskos K
J Mol Biol; 2011 Sep; 412(2):251-66. PubMed ID: 21806996
[TBL] [Abstract][Full Text] [Related]
78. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
Alimohammadi N; Koosha F; Rafeian-Kopaei M
Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
[TBL] [Abstract][Full Text] [Related]
79. Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease.
Chen JA; Ma H; Liu Z; Tian J; Lu S; Fang W; Ze S; Lu W; Xie Q; Huang J; Wang Y
J Med Chem; 2022 Jan; 65(1):592-615. PubMed ID: 34957834
[TBL] [Abstract][Full Text] [Related]
80. CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.
Liang J; Chen M; Hughes D; Chumanevich AA; Altilia S; Kaza V; Lim CU; Kiaris H; Mythreye K; Pena MM; Broude EV; Roninson IB
Cancer Res; 2018 Dec; 78(23):6594-6606. PubMed ID: 30185549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
